Fig. 4From: Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)conditioning regimens, conditioning intensity, GvHD prophylaxis used, PTCY dose and timing as well as use of ATGBack to article page